Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) Assets Average (2016 - 2025)

Historic Assets Average for RedHill Biopharma (RDHL) over the last 13 years, with Q2 2025 value amounting to $18.2 million.

  • RedHill Biopharma's Assets Average fell 1919.86% to $18.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.2 million, marking a year-over-year decrease of 1919.86%. This contributed to the annual value of $20.5 million for FY2024, which is 7741.28% down from last year.
  • Latest data reveals that RedHill Biopharma reported Assets Average of $18.2 million as of Q2 2025, which was down 1919.86% from $20.0 million recorded in Q4 2024.
  • RedHill Biopharma's Assets Average's 5-year high stood at $211.9 million during Q2 2021, with a 5-year trough of $18.2 million in Q2 2025.
  • Its 5-year average for Assets Average is $121.3 million, with a median of $160.3 million in 2022.
  • Per our database at Business Quant, RedHill Biopharma's Assets Average surged by 8400.86% in 2021 and then plummeted by 8162.26% in 2023.
  • RedHill Biopharma's Assets Average (Quarter) stood at $183.8 million in 2021, then dropped by 14.0% to $158.0 million in 2022, then crashed by 81.62% to $29.0 million in 2023, then plummeted by 31.02% to $20.0 million in 2024, then fell by 9.11% to $18.2 million in 2025.
  • Its Assets Average was $18.2 million in Q2 2025, compared to $20.0 million in Q4 2024 and $22.5 million in Q2 2024.